These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 517534)

  • 21. Relationship between length of time and contamination in open intravenous solutions.
    Amonsen S; Gren JE
    Nurs Res; 1978; 27(6):372-4. PubMed ID: 251249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
    Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM
    Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assuring the quality of intravenous admixture programs.
    Stolar MH
    Am J Hosp Pharm; 1979 May; 36(5):605-8. PubMed ID: 453213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sterility testing of a total nutrient admixture with a biphasic blood-culture system.
    Murray PR; Sandrock MJ
    Am J Hosp Pharm; 1991 Nov; 48(11):2419-21. PubMed ID: 1746575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Craft DA; Lizer MH
    Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of a new intravenous device].
    Lustig A; Yofee A; Sokol R
    Harefuah; 1993 Sep; 125(5-6):133-5, 192. PubMed ID: 8225089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sterility of total parenteral nutrient solutions stored at room temperature for seven days.
    Takagi J; Khalidi N; Wolk RA; Tjolsen E; de Leon R; Wesley JR
    Am J Hosp Pharm; 1989 May; 46(5):973-7. PubMed ID: 2499191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Word-processing system in a centralized intravenous admixture program.
    Kirschenbaum BE
    Am J Hosp Pharm; 1982 Oct; 39(10):1690-2. PubMed ID: 6816065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temperature of refrigerated i.v. fluids and admixtures during infusion.
    Stiles ML; Mickschl D; Thompson DF
    Am J Hosp Pharm; 1989 May; 46(5):977-9. PubMed ID: 2499192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids.
    Cloyd JC; Bosch DE; Sawchuk RJ
    Am J Hosp Pharm; 1978 Jan; 35(1):45-8. PubMed ID: 623117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on microbial contamination of infusion fluids arising from drug additions and administration.
    Ernerot L; Thorén S; Sandell E
    Acta Pharm Suec; 1973 May; 10(2):141-6. PubMed ID: 4728099
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality of intravenous infusion fluids manufactured in Kenya.
    Aluoch-Orwa JA; Ondari CO; Kibwage IO; Hoogmartens J
    East Afr Med J; 1995 Dec; 72(12):800-4. PubMed ID: 8689981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions.
    Yuen PH; Taddei CR; Wyka BE; Chaudry IA
    Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endemic intravenous fluid contamination in pediatric wards].
    Muñoz JM; Zapién R; Ponce-De-León S; Alvarez JA; Mosqueda JL; Gallaga JC; Macías AE
    Rev Invest Clin; 2009; 61(5):378-82. PubMed ID: 20184097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids.
    Lesko LJ; Marion A; Ericson J; Siber GR
    Am J Hosp Pharm; 1981 Jul; 38(7):1004-6. PubMed ID: 7258196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial contamination of platelet concentrates prepared by different methods: results of standardized sterility testing in Germany.
    Walther-Wenke G; Doerner R; Montag T; Greiss O; Hornei B; Knels R; Strobel J; Volkers P; Däubener W;
    Vox Sang; 2006 Apr; 90(3):177-82. PubMed ID: 16507017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Michelini TJ; McMahon RE
    Am J Hosp Pharm; 1987 Jul; 44(7):1620-4. PubMed ID: 3307397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.